Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 27, 2015 - Issue 4
805
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Analysis of the interrelationship of the pulmonary irritation and elicitation thresholds in rats sensitized with 1,6-hexamethylene diisocyanate (HDI)

Pages 191-206 | Received 16 Nov 2014, Accepted 27 Feb 2015, Published online: 29 Apr 2015

References

  • Aalto-Korte K, Suuronen K, Kuuliala O, et al. (2011). Occupational contact allergy to monomeric isocyanates. Contact Dermatitis 67:78–88
  • Alexandersson R, Hedenstierna G, Plato N, Kolmodin-Hedman B. (1987). Exposure, lung function, and symptoms in car painters exposed to hexamethylene diisocyanate and biuret modified hexamethylene diisocyanate. Arch Environ Health 42:367–73
  • Arts JH, de Jong WH, van Triel JJ, et al. (2008). The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol Sci 106:423–34. Toxicology 1997;117:229–34
  • Baur X. (2007). Evidence for allergic reactions in isocyanate asthma. J Allergy Clin Immunol 119:757–8
  • Baur X, Marek W, Ammon J, et al. (1994). Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health 66:141–52
  • Bello D, Herrick CA, Smith TJ, et al. (2007). Skin exposure to isocyanates: reasons for concern. Environ Health Perspect 115:328–35
  • Bello D, Woskie SR, Streicher RP, et al. (2004). Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am J Ind Med 46:480–91
  • Boverhof DR, Billington R, Gollapudi BB, et al. (2008). Respiratory sensitization and allergy: current research approaches and needs. Toxicol Appl Pharmacol 226:1–13
  • Cassidy LD, Molenaar DM, Hathaway JA, et al. (2010). Trends in pulmonary function and prevalence of asthma in hexamethylene diisocyanate workers during a 19-year period. J Occup Environ Med 52:988–94
  • Cockcroft DW, Mink JT. (1979). Isocyanate-induced asthma in an automobile spray painter. CMA 121:602–4
  • De Vooght V, Haenen S, Verbeken E, et al. (2011). Successful transfer of chemical-induced asthma by adoptive transfer of low amounts of lymphocytes in a mouse model. Toxicology 279:85–90
  • De Vooght V, Smulders S, Haenen S, et al. (2013). Neutrophil and eosinophil granulocytes as key players in a mouse model of chemical-induced asthma. Toxicol Sci 131:406–18
  • DFG (Deutsche Forschungsgemeinschaft). (2014). MAK-und BAT-Werte-Liste 2014: Maximale Arbeitsplatzkonzentrationen und Biologische Arbeitsstofftoleranzwerte. MAK Values of Hexamethylene diisocyanate (HDI) and Diphenylmethane diisocyanate (MDI). Available from: http://onlinelibrary.wiley.com/doi/10.1002/9783527682010.ch2/pdf). [Last accessed: 23 Jun 2014]
  • Directive 2010/63/EEC. (2010). Guideline of the council dated September 22, 2010 on the reconciliation of legal and administrative regulations of the member countries for the protection of animals used for studies and other scientific purposes. J Eur Commun, Legal Specifications L276, pp. 33–76
  • ECHA. (2012). Guidance on information requirements and chemical safety assessment Chapter R.8: characterization of dose [concentration]–response for human health, version: 2.1. APPENDIX R. 8-11 Respiratory sensitization, p. 130. Available from: http://echa.europa.eu/documents/10162/13632/information_requirements_r8_en.pdf. [Last accessed: Nov 2012]
  • Ewald-Kleimeier S, Lotz A, Merget R, et al. (2013). Exhaled nitric oxide in specific inhalation challenge. Adv Exp Med Biol 788:255–64
  • Janko M, McCarthy K, Fajer M, van Raalte J. (1992). Occupational exposure to 1,6-hexamethylene diisocyanate-based polyisocyanates in the state of Oregon, 1980–1990. Am Ind Hyg Assoc 53:331–8
  • Jatakanon A, Uasuf C, Maziak W, et al. (1999). Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160:1532–9
  • Jonaid BS, Pronk A, Doekes G, Heederik D. (2014). Exhaled nitric oxide in spray painters exposed to isocyanates: effect modification by atopy and smoking. Occup Environ Med 71:415–22
  • Kidd P. (2003). Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8:223–46
  • Kimber I, Dearman RJ. (2005). What makes a respiratory sensitizer? Curr Opin Allergy Clin Immunol 5:119–24
  • Kimber I, Dearman RJ, Basketter DA, Boverhof DR. (2014). Chemical respiratory allergy: reverse engineering an adverse outcome pathway. Toxicology 318:32–9
  • Laskin DL, Suni VR, Gardner CR, Laskin JD. (2010). Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51:267–88
  • Lemière C, Romeo P, Chaboillez S, et al. (2002). Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 10:641–6
  • Leroyer C, Perfetti L, Cartier A, Malo JL. (1998). Can reactive airways function syndrome (RADS) transform into occupational asthma due to “sensitization” to isocyanates? Thorax 53:152–3
  • Liu FF, Li WL, Pauluhn J, et al. (2013). Rat models of acute lung injury: exhaled nitric oxide as a sensitive, noninvasive real-time biomarker of prognosis and efficacy of intervention. Toxicology 310C:104–14
  • Maître A, Leplay A, Perdirix A, et al. (1996). Comparison between solid sampler and impinger for evaluation of occupational exposure to 1,6-hexamethylene diisocyanate (HDI) polyisocyanates during spray painting. Am Ind Hyg Assoc J 57:153–60
  • Mähler M, Berard M, Feinstein R, et al. (2014). FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim 48:178–92
  • Malo J-L, Ghezzo H, L'archevêque J, et al. (1991). Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 143:528–32
  • Myer HE, O'Block ST, Dharmarajan V. (1993). A survey of airborne HDI, HDI-based polyisocyanate and solvent concentrations in the manufacture and application of polyurethane coatings. Am Ind Hyg Assoc J 54:663–70
  • OECD. (1998). Organisation for Economic Cooperation and Development (1998). OECD Principles on Good Laboratory Practice (as revised in 1997). ENV/MC/CHEM (98) 17, distributed 26 January 1998. Paris: Organisation for Economic Cooperation and Development
  • OECD. (2009). Organization for Economic Cooperation and Development-Environment, Health and Safety Publications, Series on Testing and Assessment No. 39: Guidance Document for Acute Inhalation Toxicity Testing, [ENV/JM/MONO 28]. Available from: http://oberon.sourceoecd.org. [Last accessed: 21 Jul 2009]
  • Pauluhn J. (1994). Assessment of chemicals for their potential to induce respiratory allergy in guinea pigs: a comparison of different routes of induction and confounding effects due to pulmonary hyperreactivity. Toxicology In Vitro 8:981–5
  • Pauluhn J. (2000). Acute inhalation toxicity of polymeric diphenyl-methane-4,4'-diisocyanate (MDI) in rats: time course of changes in bronchoalveolar lavage. Arch Toxicol 74:257–69
  • Pauluhn J. (2002). Short-term inhalation toxicity of polyisocyanate aerosols in rats: comparative assessment of irritant-threshold concentrations by bronchoalveolar lavage. Inhal Toxicol 14:287–301
  • Pauluhn J. (2004). Comparative analysis of pulmonary irritation by measurements of Penh and protein in bronchoalveolar lavage fluid in Brown Norway rats and Wistar rats exposed to irritant aerosols. Inhal Toxicol 16:159–75
  • Pauluhn J. (2005). Brown Norway rat asthma model of diphenylmethane-4,4′-diisocyanate. Inhal Toxicol 17:729–39
  • Pauluhn J. (2008). Brown Norway rat asthma model of diphenylmethane-4,4′-diisocyanate (MDI): the elicitation dose–response relationship. Toxicol Sci 104:320–31
  • Pauluhn J. (2011). Interrelating the acute and chronic mode of action of inhaled methylenediphenyl diisocyanate (MDI) assisted by computational toxicology. Regul Pharmacol Toxicol 61:351–64
  • Pauluhn J. (2014). Development of a respiratory sensitization/elicitation protocol of toluene diisocyanate (TDI) in Brown Norway rats to derive an elicitation-based occupational exposure level. Toxicology 319:10–22
  • Pauluhn J, Mohr U. (2001). Inhalation toxicity of 1,6-hexamethylene diisocyanatehomopolymers (HDI-IC and HDI-BT): results of subacute and subchronic repeated exposure inhalation exposure studies. Inhal Toxicol 13:513–32
  • Pauluhn J, Mohr U. (2005). Review: experimental approaches to evaluate respiratory allergy in animal models. Exp Toxic Pathol 56:203–34
  • Pauluhn J, Poole A. (2011). Brown Norway rat asthma model of diphenylmethane-4,4-diisocyanate (MDI): determination of the elicitation threshold concentration of after inhalation sensitization. Toxicology 281:15–24
  • Pauluhn J, Thiel A. (2007). A simple approach to validation of directed-flow nose-only inhalation chambers. J Appl Toxicol 27:160–7
  • Pauluhn J, Eidmann P, Mohr U. (2002). Respiratory hypersensitivity in guinea pigs sensitized to 1,6-hexamethylene diisocyanate (HDI): comparison of results obtained with the monomer and homopolymers of HDI. Toxicology 171:147–60
  • Pauluhn J, Woolhiser MR, Bloemen L. (2005). Repeated inhalation challenge with diphenylmethane-4,4′-diisocyanate in brown Norway rats leads to a time-related increase of neutrophils in bronchoalveolar lavage after topical induction. Inhal Toxicol 17:67–78
  • Pisaniello DL, Muriale L. (1989). The use of isocyanate paints in auto refinishing – a survey of isocyanate exposures and related work practices in South Australia. Am Occup Hyg 33:563–72
  • Pronk A, Preller L, Raulf-Heimsoth M, et al. (2007). Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med 176:1090–7
  • Pronk A, Tielemans E, Skarping G, et al. (2006a). Inhalation exposure to isocyanates of car body repair shop workers and industrial spray painters. Ann Occup Hyg 50:1–14
  • Pronk A, Yu F, Vlaanderen J, et al. (2006b). Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters. Occup Environ Med 63:624–31
  • Rando RJ, Poovey HG. (1999). Development of a dichotomous vapor/aerosol sampler for HDI-derived total reactive isocyanate group. Am Ind Hyg Assoc J 60:737–46
  • Raulf-Heimsoth M, Liebig R, Marczynski B, et al. (2013). Implementation of non-invasive methods in the diagnosis of diisocyanate-induced asthma. Adv Exp Med Biol 788:293–300
  • Redlich CA. (2010). Skin exposure and asthma: is there a connection? Proc Am Thorac Soc 7:134–7
  • Redlich CA, Stowe MH, Coren BA, et al. (2002). Diisocyanate-exposed auto body shop workers: a one-year follow-up. Am J Ind Med 42:511–18
  • Remiarz RJ, Argawal JK, Quant FR, SEM GJ. (1983). A real-time aerodynamic particle size analyzer. In: Marple VA, Liu BYH (eds.) Aerosols in the mining and industrial work environments. Ann Arbor, MI: Science Publ. Inc, 879–95
  • Schroeter JD, Kimbell JS, Asgharian B, et al. (2013). Inhalation dosimetry of hexamethylene diisocyanate vapor in the rat and human respiratory tracts. Inhal Toxicol 25:168–77
  • Shiba T, Maruyama T, Kurohane K, et al. (2009). TRPA1 and TRPV1 activation is a novel adjuvant effect mechanism in contact hypersensitivity. J Neuroimmunol 207:66–74
  • Shiotsuka RN, Stuart BP, Charles JM, et al. (2010). Chronic inhalation exposure of Fischer 344 rats to 1,6-hexamethylene diisocyanate did not reveal a carcinogenic potential. Inhal Toxicol 22:875–87
  • Shiotsuka RN, Stuart BP, Sangha GK, et al. (2006). Subacute inhalation exposure of rats to 1,6-hexamethylene diisocyanate. Inhal Toxicol 18:659–65
  • Thomasen JM, Fent KW, Nylander-French LA. (2011). Development of a sampling patch to measure dermal exposures to monomeric and polymeric 1,6-hexamethylene diisocyanate: a pilot study. J Occup Environ Hyg 8:709–17
  • Thorne PS, Hillebrand JA, Lewis GR, Karol MH. (1987). Contact sensitivity by diisocyanates: potencies and cross-reactivities. Toxicol Appl Pharmacol 87:155–65
  • Tornling G, Alexandersson R, Hedenstierna G, Plato N. (1990). Decreased lung function and exposure to diisocyanates (HDI and HDI-BT) in car repair painters: observations on re-examination 6 years after initial study. Am J Ind Med 17:299–310
  • Vandenplas O. (2011). Occupational asthma: etiologies and risk factors. Allergy Asthma Immunol Res 3:157–67
  • Vandenplas O, Cartier A, Lesage J, et al. (1993a). Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J Allergy Clin Immunol 91:850–61
  • Vandenplas O, Cartier A, Ghezzo H, et al. (1993b). Response to isocyanates: effect of concentration, duration of exposure, and dose. Am Rev Respir Dis 147:1287–90
  • Vandenplas O, Malo J-L, Saetta M, et al. (1993c). Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives. Br J Ind Med 50:213–28
  • Vanoirbeek JA, De Vooght V, Vanhooren HM, et al. (2007). How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? J Allergy Clin Immunol 121:456–63
  • Villeneuve DL, Crump D, Garcia-Reyero N, et al. (2014). Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci 142:312–20